Found 41 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Title is B  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C. Schmidt, Smith, C., Barin, B., Bakhtyari, A., Bart, P. A., Bekker, L. G., Chomba, E., Clumeck, N., Ho, D., Hoosen, A., Jaoko, W., Kaleebu, P., Karita, E., Keefer, M. C., Lunzen, J. V., McMichael, A., Mehendale, S., Peters, B., Ramanathan, V. D., Robinson, A., Rockstroh, J., Vardas, E., Vets, E., Weber, J., Graham, B. S., Than, S., Excler, J. L., Kochhar, S., Ho, M., Heald, A., and Fast, P. E., Background Morbidity in HIV Vaccine Trial Participants From Various Geographic Regions as Assessed by Unsolicited Adverse Events, Hum Vaccin Immunother, vol. 8, no. 5, pp. 630-638, 2012.
L. C. Racusen, Solez, K., Colvin, R. B., Bonsib, S. M., Castro, M. C. R., Cavallo, T., Croker, B. P., Demetris, A. J., Drachenberg, C. B., Fogo, A. B., Furness, P., Gaber, L. W., Gibson, I. W., Glotz, D. G., Goldberg, J. C., Grande, J., Halloran, P. F., Hansen, H. E., Hartley, B., Hayry, P. J., and Hill, C. Mand, The Banff 97 working classification of renal allograft pathology, Kidney Int., vol. 55, pp. 713-23, 1999.
J. May, Salazar, D., Novo, P., Shmueli-Blumberg, D., Matthews, A., and Rotrosen, J., Baseline Characteristics by Randomization Status in the Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Clinical Trial, in College on Problems of Drug Dependence Sceintific Meeting, Montreal, Quebec, Canada, 2017.
T. E. Clemons, Gillies, M. C., Chew, E. Y., Bird, A. C., Peto, T., Figueroa, M. J., and Harrington, M. W., Baseline Characteristics of Participants in the Natural History Study of Macular Telangiectasia (MacTel) MacTel Project Report No. 2, Ophthalmic Epidemiol, vol. 17, no. 1, pp. 66-73, 2010.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., King, J., Antoszyk, A. N., Peters, M. A., and Tolentino, M., Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4, JAMA Ophthalmol, vol. 135, no. 6, pp. 639-649, 2017.
W. Stevens, Kamali, A., Karita, E., Anzala, O., Sanders, E. J., Jaoko, W., Kaleebu, P., Mulenga, J., Dally, L., Fast, P., Gilmour, J., Farah, B., Birungi, J., Hughes, P., Manigart, O., Stevens, G., Yates, S., Thomson, H., ,, Stoll-Johnson, L., and Ketter, N., Baseline Morbidity in 2,990 Adult African Volunteers Recruited to Characterize Laboratory Reference Intervals for Future HIV Vaccine Clinical Trials, PLoS ONE, vol. 3, p. e2043, 2008.
A. D. Meleth, SanGiovanni, J. P., Chew, E. Y., Gensler, G., and Clemons, T. E., Baseline Nutritional Characteristics of the Age-Related Eye Disease Study 2 (AREDS2) Cohort, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2009.
Baseline Nutritional Status of AREDS Participants, Poster Presentation by AREDS Participants, Experimental Biology, 1999.
A. Meehan, Searing, E., Weaver, L. K., and Raizada, H., Baseline Oculomotor, Vestibular, and Balance Findings in the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen for Persistent Post-Concussive Symptoms After Mild Traumatic Brain Injury (mTBI) Study, in The 2015 Gordon Research Conference (GRC) "Eye Movements" , Waltham, MA, 2015.
L. P. Aiello, Vignati, L., Sheetz, M. J., Zhi, X., Girach, A., Davis, M. D., and Milton, R. C., Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss, in 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG), Berlin, Germany, 2005.
I. Scott, Van Veldhuisen, P., Oden, N., Ip, M., Blodi, B., Hartnett, M., and Cohen, G., Baseline Predictors of Visual Acuity and Retinal Thickness Outcomes in Patients with Retinal Vein Occlusion. SCORE Study Report 10, Ophthalmology, vol. 118, no. 2, pp. 345-352, 2011.
N. Oden and Kim, J. H., Bayesian Prediction of Enrollment in Clinical Trials, 2006.
S. Ramani, Neill, F. H., Ferreira, J., Treanor, J. J., Frey, S. E., Topham, D. J., Goodwin, R. R., Borkowski, A., Baehner, F., Mendelman, P. M., Estes, M. K., and Atmar, R. L., B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine., Clin Vaccine Immunol, vol. 24, no. 5, 2017.
S. DM, Beneficial effect on non-inherited maternal antigens on graft survival in pediatric renal transplantation,, J Am Soc Nephrol, vol. 7, p. 1917, 1996.
M. Ebtia, Murphy, D., Gin, K., Lee, P., Jue, J., Nair, P., Mayo, J., Barnes, M., Thompson, D., and Tsang, T. S., Best Method for Right Atrial Volume Assessment by Two-Dimensional Echocardiography: Validation with Magnetic Resonance Imaging, Echocardiography, vol. 32, pp. 734-739, 2015.
D. Blumberg, Novo, P., Jeffries, B., Yesko, L., Matthews, A., Collins, J., Salazar, D., Jelstrom, E., Wright, M., Kondapaka, R., and Lindblad, R., Best Practices for Study Drug Management and Accountability Throughout the Study Lifecycle in Multi-Site Randomized Controlled Trials, in Society for Clinical Trials 38th Annual Meeting, Liverpool, UK, 2017.
L. A. Frasetto, Tan-Tam, C. C., Barin, B., Browne, M., Wolfe, A. R., Stock, P. G., Roland, M., and Benet, L. Z., Best Single Time Point Correlations with AUC for Cyclosporine and Tacrolimus in HIV-Infected Kidney and Liver Transplant Recipients, Transplantation, vol. 97, pp. 702-707, 2014.
L. Frassetto, Tan-Tam, C., Barin, B., Browne, M., Wolfe, A., Stock, P., Roland, M., and Benet, L., The Best Single Time Point Measurement Correlations with AUC for Cyclosporine and Tacrolimus in HIV-1 Infected Liver and Kidney Transplant Recipients (poster session), in World Congress of Nephrology, Vancouver, Canada, 2011.
S. P. Buckelew, Conway, M. D., Parker, J. C., Deuser, W. E., Jennings, J., Wity, T. E., Hewett, J. E., Minor, M., Johnson, J. C., Male, L. V., McIntosh, M. J., Nigh, M., ,, and Kay, D. R., Biofeedback/relaxation training and exercise intervention for fibromyalgia: A prospective trial, Arthritis Care and Research, vol. 11, pp. 196-209, 1998.
A. Letizia, Eller, M. A., Polyak, C., Eller, L. Anne, Creegan, M., Dawson, P., Bryant, C., Dohoon, K., Crowell, T. A., Lombardi, K., Rono, E., Robb, M. L., Michael, N. L., Maswai, J., and Ake, J. A., Biomarkers of Inflammation Correlate with Clinical Scoring Indices in HIV-Infected Kenyans., J Infect Dis, 2018.
Y. Ding, Liu, Y., Yan, Q., Fritsche, L. G., Cook, R. J., Clemons, T., Ratnapriya, R., Klein, M. L., Abecasis, G. R., Swaroop, A., Chew, E. Y., Weeks, D. E., and Chen, W., Bivariate Analysis of Age-Related Macular Degeneration Progression Using Genetic Risk Scores, Genetics, 2017.
H. H. Hirsch, Barin, B., Kardas, P., Stock, P., and Blumberg, E. A., BK and JC Polyomavirus (PyV) in HIV-1 Infected Kidney Transplant Recipients (KTR), in Interscience Conference on Antimicrobial Agents and Chemotherapy - ICAAC 2013, Denver, CO, 2013.
E. Blumberg, Barin, B., Bloom, R., Roland, M., Olsen, J., Murphy, B., Pavlakis, M., Roth, D., Moore, J., Cangro, C., Saltzberg, S., Fine, D., Josephson, M., Guasch, A., Lobo, P., Zhang, R., Gallon, L., Gonin, J., Fatica, R., Mogilshetty, G., and Stock, P., BK Virus is Not a Significant Cause of Graft Loss in HIV+ Kidney Recipients (oral presentation), presented at the 2011, Philadelphia, PA, 2011.
J. M. Smith, Dharnidharka, V. R., Talley, L., Martz, K., and McDonald, R. A., BK Virus Nephropathy in Pediatric Renal Transplant Recipients: An Analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) Registry, Clin J Am Soc Nephrol, vol. 2, no. 5, pp. 1037-1042, 2007.
D. Weisdorf, Carter, S., Confer, D., Ferrara, J., and Horowitz, M., Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions, Biol Blood Marrow Transplant, vol. 13, no. 3, pp. 257-262, 2007.